Curtain up, drum roll, Frank Thelen enters the stage. Some time ago he judged the inventions of young entrepreneurs as a TV jury member in the “Höhle der Löwen”. Now he has come up with a business idea that others can judge. Thelen, author and head of the venture capital company Freigeist, makes private investors' mouth watery. He does this with an equity fund that has a similar name to his book published in 2020, namely “10xDNA - Disruptive Innovation”. It is about companies that are changing the world: be it with artificial intelligence, quantum computers or blockchain. Hot irons that Thelen tackles, true to his philosophy as a venture capitalist.
Germany actually has enough celebrity funds. Be it the “Future Fund” for which the former Bild editor-in-chief Kai Diekmann holds out his head, be it the “Grönemeyer Sustainable Health Fund” of the medical doctor and musician brother Dietrich Grönemeyer, not to mention the products of the crash prophets that on Put gold and Bitcoin, or the mixed fund "Dirk Müller Premium Aktien" of the former stock exchange trader.
But wait: not all celebrity funds are created equal. So Thelen is, so to speak, the anti-Müller: While he is fully on risk, Müller wants above all to avoid losses (which has been going wrong for three years). For the normal investor with an average risk profile, one is as unsuitable as the other. Thelens Tech-Fonds with 30 stocks will foreseeably fluctuate strongly in value. In addition, the values contained therein such as Tesla, Tencent and Palantir are already very expensive, so that the air is getting thinner. It is extremely ambitious that Thelen aims to triple its value within four to eight years. If you still want to set up your portfolio with disruptive companies with more opportunities, you can do this more cheaply with an index fund. What such ETFs lack is a colorful name. But that shouldn't be a criterion for investors.